UPDATE: Canaccord Genuity Downgrades Momenta Pharmaceuticals (MNTA) to Hold; Negative Copaxone Ruling
Tweet Send to a FriendGet Alerts MNTA Hot Sheet
Price: $13.03 -0.08%
Rating Summary:
3 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
3 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade MNTA Now!
(Updated - June 25, 2012 8:23 AM EDT)
Canaccord Genuity downgraded Momenta Pharmaceuticals (NASDAQ: MNTA) from Buy to Hold with a price target of $12.00 (from $17.00).
Analyst, Ritu Baral, said, "M-enox revenues are now a modest royalty stream. Friday’s negative ruling on Copaxone delays potential launch of M356 (generic Copaxone). While MNTA's Baxter-partnered biosimilars program and branded drugs have significant long-term potential, lack of near-term catalysts likely limits 12-month upside."
For an analyst ratings summary and ratings history on Momenta Pharmaceuticals click here. For more ratings news on Momenta Pharmaceuticals click here.
Shares of Momenta Pharmaceuticals closed at $17.01 yesterday, with a 52 week range of $10.15-$21.00.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Canaccord Genuity downgraded Momenta Pharmaceuticals (NASDAQ: MNTA) from Buy to Hold with a price target of $12.00 (from $17.00).
Analyst, Ritu Baral, said, "M-enox revenues are now a modest royalty stream. Friday’s negative ruling on Copaxone delays potential launch of M356 (generic Copaxone). While MNTA's Baxter-partnered biosimilars program and branded drugs have significant long-term potential, lack of near-term catalysts likely limits 12-month upside."
For an analyst ratings summary and ratings history on Momenta Pharmaceuticals click here. For more ratings news on Momenta Pharmaceuticals click here.
Shares of Momenta Pharmaceuticals closed at $17.01 yesterday, with a 52 week range of $10.15-$21.00.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'
- Janney Montgomery Scott Downgrades Aruba Networks (ARUN) to Neutral
- JPMorgan Downgrades Aruba Networks (ARUN) to Underweight
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Canaccord Genuity
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
